• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素诱导甲状腺乳头状癌细胞增殖与Bcl-xL表达改变有关。

Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL.

作者信息

Lee M L, Chen G G, Vlantis A C, Tse G M K, Leung B C H, van Hasselt C A

机构信息

Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, China.

出版信息

Cancer J. 2005 Mar-Apr;11(2):113-21. doi: 10.1097/00130404-200503000-00006.

DOI:10.1097/00130404-200503000-00006
PMID:15969986
Abstract

PURPOSE

One of the features of thyroid carcinoma is its predilection for women of reproductive age relative to men. An increased risk has also been documented in women who have used estrogens for gynecologic reasons. The aim of this study was to explore the mechanism by which sex hormones contribute to the development of thyroid carcinoma, which is not well understood at present.

MATERIALS AND METHODS

In this study, we investigated the effects of estradiol and testosterone on cell proliferation in a human thyroid papillary carcinoma cell line (KAT5) by MTT assay. We also studied the expression of estrogen receptors and the levels of anti-apoptotic Bcl-xL protein, pro-apoptotic Bax protein, and messenger RNA in the cells by Western blot and reverse transcriptase polymerase chain reaction analysis.

RESULTS

The results showed that estradiol promotes cell proliferation when compared with cells treated with testosterone and untreated cells, and that the growth-promoting effect of estradiol was attenuated by tamoxifen. The expression of Bcl-xL was markedly increased in a dose-dependent manner, resulting in an elevated ratio of Bcl-xL to Bax.

DISCUSSION

We conclude that estradiol promotes KAT5 cell proliferation and that the underlying mechanism may be associated with up-regulation of Bcl-xL expression. The data provide insight into the molecular mechanism underlying the epidemiologic data that shows a two- to threefold increased prevalence of thyroid carcinoma in women relative to men. From the therapeutic point of view, the finding that estradiol enhances anti-apoptotic signaling pathways may be significant in the search for novel prevention and treatment strategies of thyroid carcinomas.

摘要

目的

甲状腺癌的特征之一是相对于男性,其更易发生于育龄女性。有文献记载,因妇科原因使用雌激素的女性患甲状腺癌的风险也会增加。本研究的目的是探讨目前尚不清楚的性激素促进甲状腺癌发生发展的机制。

材料与方法

在本研究中,我们通过MTT法研究了雌二醇和睾酮对人甲状腺乳头状癌细胞系(KAT5)细胞增殖的影响。我们还通过蛋白质免疫印迹法和逆转录聚合酶链反应分析研究了细胞中雌激素受体的表达以及抗凋亡蛋白Bcl-xL、促凋亡蛋白Bax的水平和信使核糖核酸。

结果

结果显示,与用睾酮处理的细胞和未处理的细胞相比,雌二醇促进细胞增殖,并且他莫昔芬减弱了雌二醇的促生长作用。Bcl-xL的表达以剂量依赖性方式显著增加,导致Bcl-xL与Bax的比值升高。

讨论

我们得出结论,雌二醇促进KAT5细胞增殖,其潜在机制可能与Bcl-xL表达上调有关。这些数据为流行病学数据背后的分子机制提供了见解,该数据显示女性甲状腺癌的患病率比男性高两到三倍。从治疗角度来看,雌二醇增强抗凋亡信号通路这一发现可能对寻找甲状腺癌的新型预防和治疗策略具有重要意义。

相似文献

1
Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL.雌激素诱导甲状腺乳头状癌细胞增殖与Bcl-xL表达改变有关。
Cancer J. 2005 Mar-Apr;11(2):113-21. doi: 10.1097/00130404-200503000-00006.
2
The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.雌激素受体亚型在乳头状和间变性甲状腺癌发生发展中的作用。
J Pathol. 2008 Mar;214(4):425-33. doi: 10.1002/path.2297.
3
17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.17β-雌二醇通过调节雌激素受体亚型与雄激素受体的相对比值抑制睾酮诱导的 HepG2 细胞增殖。
J Cell Biochem. 2018 Nov;119(10):8659-8671. doi: 10.1002/jcb.27111. Epub 2018 Jul 30.
4
Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.藤黄脂,一种乙酰转移酶抑制剂,可抑制由17β-雌二醇促进的乳腺癌细胞系MCF-7的增殖。
Asian Pac J Cancer Prev. 2014;15(12):5001-7. doi: 10.7314/apjcp.2014.15.12.5001.
5
Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.一种新型bcl-2/bcl-xL双特异性反义寡核苷酸对不同组织学来源肿瘤的活性。
J Natl Cancer Inst. 2001 Mar 21;93(6):463-71. doi: 10.1093/jnci/93.6.463.
6
Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.Bcl-XL蛋白水平决定胰腺癌的凋亡指数。
Pancreas. 2005 May;30(4):337-42. doi: 10.1097/01.mpa.0000160282.64451.f1.
7
Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis.甲状腺肿瘤中Bcl-2和Bax的表达:免疫组织化学和蛋白质印迹分析
Virchows Arch. 1997 Feb;430(2):125-30. doi: 10.1007/BF01008033.
8
Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.睾酮和雌二醇对人甲状腺乳头状癌和滤泡状癌细胞系的增殖具有特定的差异调节作用,且独立于促甲状腺激素的作用。
Endocr Pathol. 2001 Fall;12(3):315-27. doi: 10.1385/ep:12:3:315.
9
c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.c-Myc过表达通过调节Bcl-2/Bcl-xL的表达,使Bim介导的Bax激活对组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸(SAHA)诱导的细胞凋亡敏感。
Int J Biochem Cell Biol. 2007;39(5):1016-25. doi: 10.1016/j.biocel.2007.01.024. Epub 2007 Feb 2.
10
P2Y receptors activate neuroprotective mechanisms in astrocytic cells.P2Y受体激活星形胶质细胞中的神经保护机制。
J Neurochem. 2004 Oct;91(1):119-32. doi: 10.1111/j.1471-4159.2004.02699.x.

引用本文的文献

1
Trends of Pathological Findings in Patients with Thyroid Diseases: A Single-center, Retrospective Study.甲状腺疾病患者的病理检查结果趋势:一项单中心回顾性研究
Clin Med Insights Endocrinol Diabetes. 2024 Nov 9;17:11795514241299709. doi: 10.1177/11795514241299709. eCollection 2024.
2
Estrogen enhances the proliferation, migration, and invasion of papillary thyroid carcinoma via the ERα/KRT19 signaling axis.雌激素通过ERα/KRT19信号轴增强甲状腺乳头状癌的增殖、迁移和侵袭。
J Endocrinol Invest. 2025 Mar;48(3):653-670. doi: 10.1007/s40618-024-02473-5. Epub 2024 Oct 25.
3
The Pattern of Thyroid Cancers in Nigeria: a Systematic Review and Meta-analysis.
尼日利亚甲状腺癌的模式:系统评价与荟萃分析。
Indian J Surg Oncol. 2024 Sep;15(Suppl 3):440-455. doi: 10.1007/s13193-024-02021-w. Epub 2024 Jul 15.
4
Incidence and pattern of second primary cancer in patients diagnosed with primary cancer.原发性癌症确诊患者中第二原发性癌症的发病率及模式。
Oncol Lett. 2024 Sep 5;28(5):535. doi: 10.3892/ol.2024.14668. eCollection 2024 Nov.
5
Enhancing clinical decision-making: A novel nomogram for stratifying cancer-specific survival in middle-aged individuals with follicular thyroid carcinoma utilizing SEER data.提高临床决策水平:利用监测、流行病学与最终结果(SEER)数据建立的一种新型列线图,用于对中年滤泡性甲状腺癌患者的癌症特异性生存进行分层。
Heliyon. 2024 May 25;10(11):e31876. doi: 10.1016/j.heliyon.2024.e31876. eCollection 2024 Jun 15.
6
Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.促甲状腺激素受体 D633H 敲入小鼠中海马状激酶信号的激活与甲状腺乳头状癌的发生。
Eur Thyroid J. 2023 Oct 3;12(6). doi: 10.1530/ETJ-23-0049. Print 2023 Dec 1.
7
RELATIONSHIP BETWEEN BODY MASS INDEX AND PATOHISTOLOGICAL FEATURES OF THYROID CANCER.体重指数与甲状腺癌的病理特征之间的关系。
Acta Clin Croat. 2022 Nov;61(3):469-475. doi: 10.20471/acc.2022.61.03.11.
8
Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells.雄激素受体激活诱导甲状腺癌细胞衰老。
Cancers (Basel). 2023 Apr 7;15(8):2198. doi: 10.3390/cancers15082198.
9
Sex differences in drug effects and/or toxicity in oncology.肿瘤学中药物效应和/或毒性的性别差异。
Curr Res Pharmacol Drug Discov. 2023 Jan 16;4:100152. doi: 10.1016/j.crphar.2022.100152. eCollection 2023.
10
Uterine fibroids increase the risk of thyroid goiter and thyroid nodules.子宫肌瘤增加甲状腺肿和甲状腺结节的风险。
Sci Rep. 2022 Apr 22;12(1):6620. doi: 10.1038/s41598-022-10625-x.